Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

MAMMALIAN PHENOTYPE - ANNOTATIONS

The Mouse Adult Gross Anatomy Ontology and Mammalian Phenotype Ontology are downloaded weekly from the Mouse Genome Informatics databases at Jackson Laboratories (ftp://ftp.informatics.jax.org/pub/reports/index.html). For more information about these ontologies, see the MGI Publications Page at http://www.informatics.jax.org/mgihome/other/publications.shtml.

Term:increased T cell derived lymphoma incidence
go back to main search page
Accession:MP:0002024 term browser browse the term
Definition:higher than normal incidence of a group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes
Synonyms:related_synonym: T cell derived lymphoma;   thymic lymphoma;   thymic tumor;   thymic tumour;   thymus tumor;   thymus tumour
 alt_id: MP:0003832;   MP:0005234



show annotations for term's descendants           Sort by:
increased T cell derived lymphoma incidence term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tls1 T-lymphoma susceptibility QTL 1 IAGP RGD PMID:10360666 RGD:619600 NCBI chr 5:90,450,144...135,450,144 JBrowse link
Q Tls2 T-lymphoma susceptibility QTL 2 IAGP RGD PMID:10360666 RGD:619600 NCBI chr 7:80,221,299...109,401,111 JBrowse link
Q Tls3 T-lymphoma susceptibility QTL 3 IAGP RGD PMID:10360666 RGD:619600 NCBI chr10:51,774,612...95,600,334 JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  mammalian phenotype 5402
    endocrine/exocrine gland phenotype 394
      abnormal gland morphology 333
        increased gland tumor incidence 86
          increased thymus tumor incidence 21
            increased T cell derived lymphoma incidence 21
              increased lymphoblastic lymphoma incidence 0
Path 2
Term Annotations click to browse term
  mammalian phenotype 5402
    neoplasm 244
      abnormal tumor susceptibility 236
        abnormal tumor incidence 225
          increased tumor incidence 166
            increased organ/body region tumor incidence 139
              increased hemolymphoid system tumor incidence 30
                increased lymphoma incidence 23
                  increased T cell derived lymphoma incidence 21
                    increased lymphoblastic lymphoma incidence 0
paths to the root